49 employees
Sitryx is a biopharmaceutical company develops disease modifying therapeutics in immuno-oncology and immuno-inflammation.
2018
$30M
from 3 investors over 3 rounds
SITRYX THERAPEUTICS LIMITED raised $30M on October 8, 2018
Investors: Longwood Fund, SV Life Sciences and Sofinnova Partners